{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:15:31Z","timestamp":1769634931132,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-024-04926-5","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T07:03:40Z","timestamp":1722582220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of the apoptotic markers Apo1\/Fas and cCK-18 and the adhesion molecule ICAM-1 with Type 1 diabetes mellitus in children and adolescents"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-7537","authenticated-orcid":false,"given":"Eirini","family":"Kostopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Efthymia","family":"Katsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Foti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bessie E.","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-2131","authenticated-orcid":false,"given":"Andrea Paola","family":"Rojas Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"4926_CR1","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/jci94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest. 2017;127:2881\u201391. https:\/\/doi.org\/10.1172\/jci94549.","journal-title":"J Clin Invest"},{"key":"4926_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/d41586-021-03800-z","volume":"602","author":"SJ Turner","year":"2022","unstructured":"Turner SJ, La Gruta NL. A subset of immune-system T cells branded as seeds foe Type 1 Diabetes. Nature. 2022;602:35\u20136. https:\/\/doi.org\/10.1038\/d41586-021-03800-z.","journal-title":"Nature"},{"key":"4926_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/pedi.12388","volume":"22","author":"A Pugliese","year":"2016","unstructured":"Pugliese A. Insulitis in the pathogenesis of type 1 diabetes. Pediatr Diabetes. 2016;22:31\u20136. https:\/\/doi.org\/10.1111\/pedi.12388.","journal-title":"Pediatr Diabetes"},{"key":"4926_CR4","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.2337\/db11-0090","volume":"60","author":"A Ferraro","year":"2011","unstructured":"Ferraro A, Socci C, Stabilini A, Valle A, Monti P, Piemonti L, Nano R, Olek S, Maffi P, Scavini M, et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011;60:2903\u201313. https:\/\/doi.org\/10.2337\/db11-0090.","journal-title":"Diabetes"},{"issue":"11","key":"4926_CR5","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1515\/jpem-2021-0352","volume":"34","author":"ME Katsa","year":"2021","unstructured":"Katsa ME, Kostopoulou E, Magana M, Ioannidis A, Chatzipanagiotou S, Sachlas A, Dimopoulos I, Spiliotis B, Rojas Gil AP. Association of the apoptotic marker APO1\/Fas with childen\u2019s predisposing factors for metabolic syndrome and with mean platelet volume. J Pediatr Endocrinol Metab. 2021;34(11):1393\u2013400. https:\/\/doi.org\/10.1515\/jpem-2021-0352.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4926_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/diabetes.50.3.483","volume":"50","author":"S DeFranco","year":"2001","unstructured":"DeFranco S, Bonissoni S, Cerutti F, Bona G, Bottarel F, Cadario F, Brusco A, Loffredo G, Rabbone I, Corrias A, et al. Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes. 2001;50:483\u20138. https:\/\/doi.org\/10.2337\/diabetes.50.3.483.","journal-title":"Diabetes"},{"key":"4926_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.7533326","volume":"267","author":"S Nagata","year":"1995","unstructured":"Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449\u201356. https:\/\/doi.org\/10.1126\/science.7533326.","journal-title":"Science"},{"key":"4926_CR8","doi-asserted-by":"publisher","first-page":"31277","DOI":"10.1074\/jbc.271.49.31277","volume":"271","author":"VL Cryns","year":"1996","unstructured":"Cryns VL, Bergeron L, Zhu H, Li H, Yuan J. Specific cleavage of \u03b1-Fodrin during Fas- and Tumor Necrosis Factor-induced Apoptosis is mediated by an Interleukin-1\u03b2-converting enzyme\/Ced-3 protease distinct from the Poly(ADP-ribose) polymerase protease. J Biol Chem. 1996;271:31277\u201382. https:\/\/doi.org\/10.1074\/jbc.271.49.31277.","journal-title":"J Biol Chem"},{"issue":"1","key":"4926_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1900\/RDS.2006.3.39","volume":"3","author":"C Sia","year":"2006","unstructured":"Sia C, H\u00e4nninen A. Apoptosis in autoimmune diabetes: the fate of beta-cells in the cleft between life and death. Rev Diabet Stud. 2006;3(1):39\u201346. https:\/\/doi.org\/10.1900\/RDS.2006.3.39. Spring.","journal-title":"Rev Diabet Stud."},{"issue":"8","key":"4926_CR10","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/pedi.13271","volume":"22","author":"E Kostopoulou","year":"2021","unstructured":"Kostopoulou E, Kalaitzopoulou E, Papadea P, et al. Oxidized lipid-associated protein damage in children and adolescents with type 1 diabetes mellitus: New diagnostic\/prognostic clinical markers. Pediatr Diabetes. 2021;22(8):1135\u201342. https:\/\/doi.org\/10.1111\/pedi.13271.","journal-title":"Pediatr Diabetes"},{"issue":"12","key":"4926_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1475-2840-12-171","volume":"15","author":"J Chang","year":"2013","unstructured":"Chang J, Zhang G, Zhang L, Hou YP, Liu XL, Zhang L. High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study. Cardiovasc Diabetol. 2013;15(12):171. https:\/\/doi.org\/10.1186\/1475-2840-12-171.","journal-title":"Cardiovasc Diabetol"},{"key":"4926_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J","volume":"187","author":"MP Leers","year":"1999","unstructured":"Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G, Persson B, Bjorklund P, Ramaekers FC, Bjorklund B, Nap M, et al. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol. 1999;187:567\u201372 https:\/\/doi.org\/10.1002\/(sici)1096-9896(199904)187:5%3C567::aid-path288%3E3.0.co;2-j.","journal-title":"J Pathol"},{"issue":"1","key":"4926_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/0004563218796259","volume":"56","author":"YH Chang","year":"2019","unstructured":"Chang YH, Lin HC, Hwu DW, Chang DM, Lin KC, Lee YJ. Elevated serum cytokeratin-18 concentration in patients with type 2 diabetes mellitus and non0alcoholic fatty liver disease. Ann Clin Biochem. 2019;56(1):141\u20137. https:\/\/doi.org\/10.1177\/0004563218796259.","journal-title":"Ann Clin Biochem"},{"issue":"2","key":"4926_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0753-3322(05)80078-2","volume":"59","author":"T Ueno","year":"2005","unstructured":"Ueno T, Toi M, Linder S. Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother. 2005;59(2):359\u201362. https:\/\/doi.org\/10.1016\/s0753-3322(05)80078-2.","journal-title":"Biomed Pharmacother"},{"key":"4926_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1111\/liv.12385","volume":"34","author":"JR Morling","year":"2014","unstructured":"Morling JR, Fallowfield JA, Williamson RM, Nee LD, Jackson AP, Glancy S, Reynolds RM, Hayes PC, Guha IN, Strachan MW, Price JF. Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Liver Int. 2014;34:1267\u201377. https:\/\/doi.org\/10.1111\/liv.12385.","journal-title":"Liver Int"},{"key":"4926_CR16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.7754\/clin.lab.2015.140522","volume":"61","author":"S Ramljak","year":"2015","unstructured":"Ramljak S, Hermanns I, Demircik F, Pfutzner A. Assessment of hepatic disorders in patients with type 2 diabetes by means of a panel of specific biomarkers for liver injury. Clin Lab. 2015;61:1687\u201393. https:\/\/doi.org\/10.7754\/clin.lab.2015.140522.","journal-title":"Clin Lab"},{"issue":"7","key":"4926_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/biom13071128","volume":"13","author":"S Pagano","year":"2023","unstructured":"Pagano S, Bakker SJL, Juillard C, Dullaart RPF, Vuilleumier N. Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease. Biomolecules. 2023;13(7):1128. https:\/\/doi.org\/10.3390\/biom13071128.","journal-title":"Biomolecules"},{"key":"4926_CR18","doi-asserted-by":"publisher","unstructured":"Kumari V, Sarangapani S, Krishnamurthy P, Vaitheeswaran K, Sathyabaarathi R, Rajesh M, Amali J, Umashankar V, Kumaramanickavel G, Pal SS, et al. ICAM-1K469E polymorphism is a genetic determinant for the clinical risk factors of T2D subjects with retinopathy in Indians: a population-based case\u2013control study. BMJ Open. 2012;2(4). https:\/\/doi.org\/10.1136\/bmjopen-2012-001036.","DOI":"10.1136\/bmjopen-2012-001036"},{"key":"4926_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fendo.2012.00179","volume":"3","author":"HF Gu","year":"2013","unstructured":"Gu HF, Ma J, Gu KT, Brismar K. Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol (Lausanne). 2013;3:179. https:\/\/doi.org\/10.3389\/fendo.2012.00179.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4926_CR20","doi-asserted-by":"publisher","first-page":"1128523","DOI":"10.3389\/fendo.2023.1128523","volume":"14","author":"C Fr\u00f8rup","year":"2023","unstructured":"Fr\u00f8rup C, Gerwig R, Svane CAS, Mendes Lopes de Melo J, Henriksen K, Fl\u00f8yel T, Pociot F, Kaur S, St\u00f8rling J. Characterization of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-\u03b2H5 beta cells. Front Endocrinol (Lausanne). 2023;14:1128523. https:\/\/doi.org\/10.3389\/fendo.2023.1128523.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4926_CR21","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"ADAPP Committee","year":"2024","unstructured":"Committee ADAPP. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(1):S20\u201342. https:\/\/doi.org\/10.2337\/dc24-S002.","journal-title":"Diabetes Care"},{"issue":"4","key":"4926_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/pedi.12391","volume":"18","author":"ML Marcovecchio","year":"2017","unstructured":"Marcovecchio ML, de Giorgis T, Di Giovanni I, Chiavaroli V, Chiarelli F, Mohn A. Association between markers of endothelial dysfunction and early signs of renal dysfunction in pediatric obesity and type 1 diabetes. Pediatr Diabetes. 2017;18(4):283\u20139. https:\/\/doi.org\/10.1111\/pedi.12391.","journal-title":"Pediatr Diabetes"},{"key":"4926_CR23","first-page":"1","volume":"25","author":"CL Ogden","year":"2010","unstructured":"Ogden CL, Flegal KM. Changes in terminology for childhood overweight and obesity. Natl Health Stat Report. 2010;25:1\u20135 PMID: 20939253.","journal-title":"Natl Health Stat Report"},{"key":"4926_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1172\/jci8185","volume":"105","author":"A Amrani","year":"2000","unstructured":"Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest. 2000;105:459\u201368. https:\/\/doi.org\/10.1172\/jci8185.","journal-title":"J Clin Invest"},{"issue":"1","key":"4926_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0092-8674(00)80178-6","volume":"89","author":"AV Chervonsky","year":"1997","unstructured":"Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA. The role of Fas in autoimmune diabetes. Cell. 1997;89(1):17\u201324. https:\/\/doi.org\/10.1016\/s0092-8674(00)80178-6.","journal-title":"Cell"},{"issue":"7","key":"4926_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1084\/jem.20030698","volume":"198","author":"I Apostolou","year":"2003","unstructured":"Apostolou I, Hao Z, Rajewsky K, von Boehmer H. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes. J Exp Med. 2003;198(7):1103\u20136. https:\/\/doi.org\/10.1084\/jem.20030698.","journal-title":"J Exp Med"},{"key":"4926_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/pl00000643","volume":"57","author":"K Burger","year":"2000","unstructured":"Burger K, Gimpl G, Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci. 2000;57:1577\u201392. https:\/\/doi.org\/10.1007\/pl00000643.","journal-title":"Cell Mol Life Sci"},{"key":"4926_CR28","doi-asserted-by":"publisher","first-page":"51125","DOI":"10.1074\/jbc.m304332200","volume":"278","author":"EJ Westover","year":"2003","unstructured":"Westover EJ, Covey DF, Brockman HL, Brown RE, Pike LJ. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem. 2003;278:51125\u201333. https:\/\/doi.org\/10.1074\/jbc.m304332200.","journal-title":"J Biol Chem."},{"key":"4926_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbrc.2004.05.145","volume":"320","author":"R Gniadecki","year":"2004","unstructured":"Gniadecki R. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis. Biochem Biophys Res Commun. 2004;320:165\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2004.05.145.","journal-title":"Biochem Biophys Res Commun"},{"key":"4926_CR30","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1172\/jci107145","volume":"51","author":"RA Cooper","year":"1972","unstructured":"Cooper RA, Diloy Puray M, Lando P, Greenverg MS. An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest. 1972;51:3182\u201392. https:\/\/doi.org\/10.1172\/jci107145.","journal-title":"J Clin Invest"},{"key":"4926_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0014-4800(83)90056-4","volume":"39","author":"WA Thomas","year":"1983","unstructured":"Thomas WA, Kim DN, Lee KT, Reiner JM, Schmee J. Population dynamics of arterial cells during atherogenesis. XIII. Mitogenic and cytotoxic effects of a hyperlipidemic (HL) diet on cells in advanced lesions in the abdominal aortas of swine fed an HL diet for 270\u2013345 days. Exp Mol Pathol. 1983;39:257\u201370. https:\/\/doi.org\/10.1016\/0014-4800(83)90056-4.","journal-title":"Exp Mol Pathol."},{"issue":"3","key":"4926_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.11613\/bm.2013.033","volume":"23","author":"S Cernea","year":"2013","unstructured":"Cernea S, Dobreanu M. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem Med (Zagreb). 2013;23(3):266\u201380. https:\/\/doi.org\/10.11613\/bm.2013.033.","journal-title":"Biochem Med (Zagreb)"},{"key":"4926_CR33","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/01.cir.0000065220.70220.f7","volume":"107","author":"CH Chen","year":"2003","unstructured":"Chen CH, Jiang T, Yang JH, Jiang W, Lu J, Marathe GK, Pownall HJ, Ballantyne CM, McIntyre TM, Henry PD, Yang CY. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 2003;107:2102\u20138. https:\/\/doi.org\/10.1161\/01.cir.0000065220.70220.f7.","journal-title":"Circulation"},{"key":"4926_CR34","first-page":"297","volume":"12","author":"GD Norata","year":"2002","unstructured":"Norata GD, Tonti L, Roma P, Catapano AL. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis. 2002;12:297\u2013305.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4926_CR35","first-page":"290","volume":"35","author":"JW Choi","year":"2005","unstructured":"Choi JW, Kim SK. Relationships of soluble APO-1 (Fas\/CD95) concentrations, obesity, and serum lipid parameters in healthy adults. Ann Clin Lab Sci. 2005;35:290\u20136 PMID: 16081586.","journal-title":"Ann Clin Lab Sci"},{"key":"4926_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.33549\/physiolres.932916","volume":"64","author":"I Hoffmanova","year":"2015","unstructured":"Hoffmanova I, Sanchez D, Habova V, Andel M, Tuckova L, Tlaskalova-Honova H. Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2. Physiol Res. 2015;64:537\u201346. https:\/\/doi.org\/10.33549\/physiolres.932916.","journal-title":"Physiol Res."},{"key":"4926_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MPG.0b013e31817e2bfb","volume":"47","author":"MB Vos","year":"2008","unstructured":"Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, et al. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008;47:481\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e31817e2bfb.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4926_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MPG.0b013e3181e376be","volume":"51","author":"E Fitzpatrick","year":"2010","unstructured":"Fitzpatrick E, Mitry RR, Quaglia A, Hussain MJ, DeBruyne R, et al. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr. 2010;51:500\u20136. https:\/\/doi.org\/10.1097\/MPG.0b013e3181e376be.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"4926_CR39","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/ajg.2013.168","volume":"108","author":"AE Feldstein","year":"2013","unstructured":"Feldstein AE, Alkhouri N, de Vito R, Alisi A, Lopez R, et al. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am J Gastroenterol. 2013;108:1526\u201331. https:\/\/doi.org\/10.1038\/ajg.2013.168.","journal-title":"Am J Gastroenterol"},{"key":"4926_CR40","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1515\/jpem-2018-0353","volume":"31","author":"E Nurten","year":"2018","unstructured":"Nurten E, Vogel M, Kapellen TM, Richter S, Garten A, Penke M, Schuster S, Korner A, Kiess W, Kratzsch J. Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls. J Pediatr Endocrinol Metab. 2018;31:959\u201369. https:\/\/doi.org\/10.1515\/jpem-2018-0353.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"4926_CR41","doi-asserted-by":"publisher","first-page":"SC01","DOI":"10.7860\/JCDR\/2017\/26623.10541","volume":"11","author":"N Rostampour","year":"2017","unstructured":"Rostampour N, Fekri K, Hashemi-Dehkordi E, Obodiat M. Association between vascular endothelial markers and carotid intima-media thickness in children and adolescents with Type 1 diabetes mellitus. J Clin Diagn Res. 2017;11(9):SC01\u20135. https:\/\/doi.org\/10.7860\/JCDR\/2017\/26623.10541.","journal-title":"J Clin Diagn Res."},{"key":"4926_CR42","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1096\/fj.12-215715","volume":"28","author":"K Noda","year":"2014","unstructured":"Noda K, Nakao S, Zandi S, Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J. 2014;28:2038\u201346. https:\/\/doi.org\/10.1096\/fj.12-215715.","journal-title":"FASEB J"},{"key":"4926_CR43","doi-asserted-by":"publisher","unstructured":"Martin TM, Burke SJ, Wasserfall CH, Collier JJ. Islet beta-cells and intercellular adhesion molecule-1 (ICAM-1): Integrating immune responses that influence autoimmunity and graft rejection. Autoimmun Rev. 2023;22. https:\/\/doi.org\/10.1016\/j.autrev.2023.103414.","DOI":"10.1016\/j.autrev.2023.103414"},{"key":"4926_CR44","unstructured":"Guja C, Todd JA, Welsh K, Marshall, Ionescu-Tirgoviste C. Increased transmission of intercellular adhesion-molecule 1, 469E allele in type 1 Romanian diabetic families. Diabetologia. 1999;42:A90."},{"issue":"5","key":"4926_CR45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s0198-8859(00)00101-4","volume":"61","author":"M Nishimura","year":"2000","unstructured":"Nishimura M, Obayashi H, Maruya E, Ohta M, Tegoshi H, Fukui M, Hasegawa G, Shigeta H, Kitagawa Y, Nakano K, Saji H. Nakamura N (2000) Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol. 2000;61(5):507\u201310. https:\/\/doi.org\/10.1016\/s0198-8859(00)00101-4.","journal-title":"Hum Immunol"},{"issue":"6","key":"4926_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1034\/j.1399-0039.2000.550608.x","volume":"55","author":"S Nejentsev","year":"2000","unstructured":"Nejentsev S, Laine AP, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens. 2000;55(6):568\u201370. https:\/\/doi.org\/10.1034\/j.1399-0039.2000.550608.x.","journal-title":"Tissue Antigens"},{"key":"4926_CR47","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s002510000258","volume":"52","author":"OP Kristiansen","year":"2000","unstructured":"Kristiansen OP, Nolsoe RL, Holst H, Reker S, Larsen ZM, Johannesen J, et al. The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes. Immunogenetics. 2000;52:107\u201311. https:\/\/doi.org\/10.1007\/s002510000258.","journal-title":"Immunogenetics"},{"issue":"12","key":"4926_CR48","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.2337\/dc08-0277","volume":"31","author":"J Lin","year":"2008","unstructured":"Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA. Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care. 2008;31(12):2338\u201343. https:\/\/doi.org\/10.2337\/dc08-0277.","journal-title":"Diabetes Care"},{"issue":"8","key":"4926_CR49","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3109\/02713683.2015.1094093","volume":"41","author":"Z Lv","year":"2016","unstructured":"Lv Z, Li Y, Wu Y, Qu Y. Association of ICAM-1 and HMGA1 gene variants with retinopathy in type 2 diabetes mellitus among Chinese individuals. Curr Eye Res. 2016;41(8):1118\u201322. https:\/\/doi.org\/10.3109\/02713683.2015.1094093.","journal-title":"Curr Eye Res."},{"issue":"2","key":"4926_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.diabres.2014.01.028","volume":"104","author":"H Sun","year":"2014","unstructured":"Sun H, Cong X, Sun R, Wang C, Wang X, Liu Y. Association between the ICAM-1 K469E polymorphism and diabetic retinopathy in type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract. 2014;104(2):46\u20139. https:\/\/doi.org\/10.1016\/j.diabres.2014.01.028.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"4926_CR51","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1464-5491.2006.01948.x","volume":"23","author":"J Ma","year":"2006","unstructured":"Ma J, M\u00f6llsten A, Pr\u00e1zny M, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of type 1 diabetes and diabetic nephropathy. Diabetes Med. 2006;23(10):1093\u20139. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01948.x.","journal-title":"Diabetes Med"},{"issue":"6","key":"4926_CR52","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.2337\/dc07-1960","volume":"31","author":"AS Astrup","year":"2008","unstructured":"Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. kers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care. 2008;31(6):1170\u20136. https:\/\/doi.org\/10.2337\/dc07-1960.","journal-title":"Diabetes Care"},{"key":"4926_CR53","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1002\/cbf.4037","volume":"42","author":"P Kaur","year":"2024","unstructured":"Kaur P, Dahiya R, Nandave M, Sharma K, Goyal RK. Unveiling the crucial role of intercellular adhesion molecule-1 in secondary diabetic complications. Cell Biochem Funct. 2024;42:4037. https:\/\/doi.org\/10.1002\/cbf.4037.","journal-title":"Cell Biochem Funct"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04926-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T07:06:24Z","timestamp":1722582384000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04926-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4926"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04926-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments and it was approved by the Research Ethics Committee of the University Hospital of Patras. To partake in the study, the parents of the participating children and adolescents gave their informed consent in a written format and children and adolescents their informed assent, while participation was voluntary, and anonymity was assured.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}